This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included but will usually appear in 24 hrs or less.

Rational Source
Effect of Lactobacillus rhamnosus hsryfm 1301 on the Gut Microbiota and Lipid Metabolism in Rats Fed a High-Fat Diet. βœ…
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 25 Issue 5 Pages: 687-95
Pub: 2015 May Epub: Authors Chen D , Yang Z , Chen X , Huang Y , Yin B , Guo F , Zhao H , Huang J , Wu Y , Gu R ,
Effect of Lactobacillus rhamnosus hsryfm 1301 on the Gut Microbiota and Lipid Metabolism in Rats Fed a High-Fat Diet. βœ…
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 25 Issue 5 Pages: 687-95
Pub: 2015 May Epub: Authors Chen D , Yang Z , Chen X , Huang Y , Yin B , Guo F , Zhao H , Huang J , Wu Y , Gu R ,
Lactobacillus rhamnosus GG Ameliorated Long-Term Exposure to TiO(2) Nanoparticles Induced Microbiota-Mediated Liver and Colon Inflammation and Fructose-Caused Metabolic Abnormality in Metabolism Syndrome Mice. βœ… Go to Publication βœ…
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 69 Issue 34 Pages: 9788-9799
Pub: 2021 Sep 1 Epub: 2021 Aug 12 Authors Zhao Y , Liu S , Tang Y , You T , Xu H ,
Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis. βœ… Go to Publication βœ…
Microorganisms (Microorganisms ) Vol: 10 Issue 7 Pages:
Pub: 2022 Jul 21 Epub: 2022 Jul 21 Authors Gupta H , Kim SH , Kim SK , Han SH , Kwon HC , Suk KT ,
A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease. βœ… Go to Publication βœ…
Scientific reports (Sci Rep ) Vol: 14 Issue 1 Pages: 15460
Pub: 2024 Jul 4 Epub: 2024 Jul 4 Authors Aktas B , Aslim B , Ozdemir DA ,
A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease. βœ… Go to Publication βœ…
Scientific reports (Sci Rep ) Vol: 14 Issue 1 Pages: 15460
Pub: 2024 Jul 4 Epub: 2024 Jul 4 Authors Aktas B , Aslim B , Ozdemir DA ,
Lacticaseibacillus rhamnosus LRa05 alleviated liver injury in mice with alcoholic fatty liver disease by improving intestinal permeability and balancing gut microbiota. βœ… Go to Publication βœ…
Beneficial microbes (Benef Microbes ) Vol: 15 Issue 5 Pages: 481-493
Pub: 2024 Jul 3 Epub: 2024 Jul 3 Authors Gu J , Chen Y , Wang J , Gao Y , Gai Z , Zhao Y , Xu F ,
Lacticaseibacillus rhamnosus-Derived Exopolysaccharide Attenuates D-Galactose-Induced Oxidative Stress and Inflammatory Brain Injury and Modulates Gut Microbiota in a Mouse Model. βœ… Go to Publication βœ…
Microorganisms (Microorganisms ) Vol: 10 Issue 10 Pages:
Pub: 2022 Oct 17 Epub: 2022 Oct 17 Authors Kumari M , Dasriya VL , Nataraj BH , Nagpal R , Behare PV ,
Lacticaseibacillus rhamnosus-Derived Exopolysaccharide Attenuates D-Galactose-Induced Oxidative Stress and Inflammatory Brain Injury and Modulates Gut Microbiota in a Mouse Model. βœ… Go to Publication βœ…
Microorganisms (Microorganisms ) Vol: 10 Issue 10 Pages:
Pub: 2022 Oct 17 Epub: 2022 Oct 17 Authors Kumari M , Dasriya VL , Nataraj BH , Nagpal R , Behare PV ,
Lacticaseibacillus rhamnosus LRa05 alleviates cyclophosphamide-induced immunosuppression and intestinal microbiota disorder in mice. βœ… Go to Publication βœ…
Journal of food science (J Food Sci ) Vol: 89 Issue 12 Pages: 10003-10017
Pub: 2024 Dec Epub: 2024 Nov 26 Authors Zhu M , Yang L , Kong S , Bai Y , Zhao B ,

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]